1. Immune globulin subcutaneous, human 20% solution (Xembify®), a new high concentration immunoglobulin product for subcutaneous administration. (March 2020) Authors: Alonso, William; Vandeberg, Pete; Lang, John; Yuziuk, Jeffrey; Silverstein, Rebecca; Stokes, Kenya; McBride, Dennis; Cruz, Maria; Burns, Doug; Merritt, W. Keither; Willis, Todd; Jorquera, Juan I. Journal: Biologicals Issue: Volume 64(2020) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of the liquid and lyophilized formulations of Prolastin®-C for Alpha1-Antitrypsin deficiency: Biochemical characteristics, pharmacokinetics, safety and neoantigenicity in rabbits. (November 2019) Authors: Arora, Vikram; Cruz, Maria; Lang, John; Klos, Anthony M.; Merritt, W. Keither; Price, Jeffrey; Taylor, George; Vandeberg, Pete; Wee, Kevin; Willis, Todd Journal: Biologicals Issue: Volume 62(2019) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Issue 10324 (5th February 2022) Authors: Polizzotto, Mark N.; Nordwall, Jacqueline; Babiker, Abdel G.; Phillips, Andrew; Vock, David M.; Eriobu, Nnakelu; Kwaghe, Vivian; Paredes, Roger; Mateu, Lourdes; Ramachandruni, Srikanth; Narang, Rajeev; Jain, Mamta K.; Lazarte, Susana M.; Baker, Jason V.; Frosch, Anne E.P.; Poulakou, Garyfallia; S... Journal: Lancet Issue: Volume 399:Issue 10324(2022) Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Characterization of an Anti-Ebola Virus Hyperimmune Globulin Derived From Convalescent Plasma. (27th August 2021) Authors: Ciencewicki, Jonathan M; Herbert, Andrew S; Storm, Nadia; Josleyn, Nicole M; Huie, Kathleen E; McKay, Lindsay G A; Griffiths, Anthony; Dye, John M; Willis, Todd; Arora, Vikram Journal: Journal of infectious diseases Issue: Volume 225:Number 4(2022) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins. (25th October 2021) Authors: Díez, José María; Romero, Carolina; Cruz, María; Vandeberg, Peter; Merritt, William Keither; Pradenas, Edwards; Trinité, Benjamin; Blanco, Julià; Clotet, Bonaventura; Willis, Todd; Gajardo, Rodrigo Journal: Journal of infectious diseases Issue: Volume 225:Number 6(2022) Page Start: 938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Non‐additive effect on thrombin generation when a plasma‐derived factor VIII/von Willebrand factor (FVIII/VWF) is combined with emicizumab in vitro. (25th June 2020) Authors: Bravo, María Isabel; Raventós, Aida; Pérez, Alba; Costa, Montserrat; Willis, Todd Journal: Journal of thrombosis and haemostasis Issue: Volume 18:Number 8(2020) Page Start: 1934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Plasma‐derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study. Issue 5 (2nd June 2022) Authors: Bravo, Maria Isabel; Pérez, Alba; Raventós, Aida; Grancha, Salvador; Jorquera, Juan Ignacio; Butta, Nora Viviana; Álvarez‐Román, Maria Teresa; Costa, Montserrat; Willis, Todd; Jiménez‐Yuste, Victor Journal: Haemophilia Issue: Volume 28:Issue 5(2022) Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immunoglobulin G from single plasma donor in immune globulin intravenous causes false positive pyrogen test. (May 2019) Authors: Zervos, Clark; Zimmerman, Thomas P.; Willis, Todd; Flexman, Greg; Srivastava, Jyoti; Silverstein, Rebecca; Williams, Melanie; Vandeberg, Pete; Culp, Jennifer L.; Burns, Doug; Barham, Vickie; Durham, Amy; Malinzak, David A. Journal: Biologicals Issue: Volume 59(2019) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma. Issue 6 (22nd March 2021) Authors: Vandeberg, Peter; Cruz, Maria; Diez, Jose Maria; Merritt, W. Keither; Santos, Benjamin; Trukawinski, Susan; Wellhouse, Andrea; Jose, Marta; Willis, Todd Journal: Transfusion Issue: Volume 61:Issue 6(2021) Page Start: 1705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Combination of emicizumab and factor VIII has no additive effects after reaching normal coagulation levels: Response to J Puetz (Are there additive effects between emicizumab and factor VIII?). (31st January 2021) Authors: Bravo, Maria‐Isabel; Raventós, Aida; Pérez, Alba; Costa, Montserrat; Willis, Todd Journal: Journal of thrombosis and haemostasis Issue: Volume 19:Number 2(2021) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗